Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Renner, W; Krenn-Pilko, S; Gruber, HJ; Herrmann, M; Langsenlehner, T.
Relative telomere length and prostate cancer mortality.
Prostate Cancer Prostatic Dis. 2018; 21(4):579-583 Doi: 10.1038/s41391-018-0068-3
Web of Science PubMed FullText FullText_MUG

 

Führende Autor*innen der Med Uni Graz

Renner Wilfried

Co-Autor*innen der Med Uni Graz

Gruber Hans-Jürgen

Herrmann Markus

Krenn-Pilko Sabine

Langsenlehner Tanja

Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:

Telomeres are essential for the maintenance of chromosomal integrity and telomere length has been associated with cancer risk and development. Aim of the present study was to analyze the prognostic value of leukocyte relative telomere (RTL) length in long-term prostate cancer (PCa) mortality. Blood samples of PCa patients were obtained before initiation of radiotherapy. RTL of peripheral blood leukocytes was determined by a quantitative polymerase chain reaction method in 533 patients with PCa. Main outcome was overall mortality. During a median follow-up time of 149 months, 188 (35.3%) patients died. In a univariate Cox regression analysis, RTL quartiles (longer RTL) were significantly associated with higher overall mortality (hazard ration (HR) = 1.20; 95% confidence interval (CI): 1.05-1.36; p = 0.006). In a multivariate Cox regression model including age at diagnosis, androgen deprivation therapy, and risk group (based on PSA level, GS, and T stage), RTL quartiles remained a significant predictor of higher overall mortality (HR = 1.22; 95% CI: 1.07-1.39; p = 0.003). Longer leukocyte RTL predicts higher overall mortality in patients with PCa.

Find related publications in this database (using NLM MeSH Indexing)

Aged -

Biomarkers, Tumor -

Combined Modality Therapy -

Humans -

Leukocyte Count -

Male -

Middle Aged -

Neoplasm Grading -

Neoplasm Staging -

Prognosis -

Proportional Hazards Models -

Prostatic Neoplasms - diagnosis

Prostatic Neoplasms - genetics

Prostatic Neoplasms - mortality

Prostatic Neoplasms - therapy

Telomere - genetics

Telomere Homeostasis -

© Med Uni Graz • Impressum